1-tert-Butyl 3-methyl 3-methyl-4-oxopiperidine-1,3-dicarboxylate

Name: 1-tert-Butyl 3-methyl 3-methyl-4-oxopiperidine-1,3-dicarboxylate
SKU: ACM193274532
Rating: 5 (1 reviews)

CAS

193274-53-2

Catalog Number

ACM193274532

Category

Other Products

Molecular Weight

271.309540 [g/mol]

Molecular Formula

C₁₃H₂₁NO₅

COA MSDS SDS Spec Sheet

If you have any other questions or need other size, please get a quote.

Specification

Synonyms

Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate, 193274-53-2, SureCN654686, CTK8C4696, ANW-72827, AKOS016007576, RL02437, AK-46840, KB-13306, 1-tert-butyl-3-methyl-3-methyl-4-oxopiperidine-1,3-dicarboxylate

IUPAC Name

1-O-tert-butyl 3-O-methyl 3-methyl-4-oxopiperidine-1,3-dicarboxylate

SMILES

CC1(CN(CCC1=O)C(=O)OC(C)(C)C)C(=O)OC

InChI Key

IDSNQTJSDFUAEV-UHFFFAOYSA-N

Exact Mass

271.14200

H-Bond Acceptor

H-Bond Donor

Upstream Synthesis Route 1

161491-24-3
74-88-4

193274-53-2

Reference: [1]Location in patent: experimental part
Chai, Yun; Wan, Zhi-Long; Wang, Bo; Guo, Hui-Yuan; Liu, Ming-Liang
[European Journal of Medicinal Chemistry, 2009, vol. 44, # 10, p. 4063 - 4069]
[2]Current Patent Assignee: KIRIN HOLDINGS CO LTD; TAKEDA PHARMACEUTICAL COMPANY LIMITED - US2005/70549, 2005, A1
[3]Current Patent Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED; Kyowa Kirin (in: Kirin Holdings); KIRIN HOLDINGS CO LTD - US2016/31908, 2016, A1
Location in patent: Paragraph 1393
[4]Current Patent Assignee: SPERO THERAPEUTICS INC - US2012/88750, 2012, A1
Location in patent: Page/Page column 28; 29
[5]Current Patent Assignee: JOHNSON & JOHNSON INC; IDORSIA PHARMACEUTICALS LTD - WO2018/19929, 2018, A1
Location in patent: Page/Page column 214

Downstream Synthesis Route 1

193274-53-2
873-77-8

849106-33-8

Reference: [1]Current Patent Assignee: KIRIN HOLDINGS CO LTD; TAKEDA PHARMACEUTICAL COMPANY LIMITED - US2005/70549, 2005, A1
[2]Current Patent Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED; Kyowa Kirin (in: Kirin Holdings); KIRIN HOLDINGS CO LTD - US2016/31908, 2016, A1
Location in patent: Paragraph 1394

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.